Degenerative Arthritis
Pipeline by Development Stage
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (14)
Total enrollment: 1,008 patients across 14 trials
A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis
Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis
Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis
Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis
Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis
Safety and Biological Efficacy Study of TisssueGene-C to Degenerative Arthritis
Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy
Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration
Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.
Zimmer Trabecular Metal Total Ankle PMCF
I-beam and Cruciate Tibial Components Used in Total Knee Replacement
Total Knee Replacement With Duracon® and Vanguard™ Prostheses
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.